Hemraj Badal's NPR 41 Crore Pharma Business Has Its Sights Beyond Nepal
With NPR 40.88 crore in annual revenue, NPR 77.45 crore in reported net worth and a NPR 17 crore IPO approved, Kantipur Pharmaceuticals is looking beyond Nepal through South Korean technical expertise and ambitions to enter international markets.
